CD5-CAR T cell therapy (Nanobody)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD5-CAR T cell therapy (Nanobody), covering 2025-11-26 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies [Phase 1, Phase 2]